Learn about Infantile Refsum Disease Treatment in Turkey — how it works, who it is for, recovery timelines, and what to expect before and after surgery. Compare hospitals and doctors experienced in Infantile Refsum Disease and request assistance for cost estimates or appointments.

About Infantile Refsum Disease

Infantile Refsum Disease (IRD) is a rare, inherited metabolic disorder managed by a neurologist, not a single procedure. It is a peroxisomal biogenesis disorder characterized by the body's inability to break down phytanic acid, a type of fat found in certain foods. Neurologists lead a comprehensive, lifelong management plan focused on slowing disease progression and managing symptoms. This involves strict dietary modification to limit phytanic acid intake, supportive therapies like physical and occupational therapy, and regular monitoring for complications such as vision loss, hearing impairment, and neurological decline. Early diagnosis and intervention are crucial for optimizing quality of life and functional outcomes for affected infants and children.

Key Highlights

    Focuses on halting the accumulation of toxic phytanic acid in the body.Aims to preserve existing vision and hearing for as long as possible.Slows the progression of neurological damage and developmental delays.Improves overall quality of life and functional abilities through multidisciplinary support.Provides a structured, lifelong care plan tailored to the individual's needs.

Who is this surgery for?

  • Diagnosis of Infantile Refsum Disease based on clinical presentation and confirmed by genetic testing or elevated blood phytanic acid levels.
  • Presence of key symptoms: severe visual impairment (retinitis pigmentosa), hearing loss, developmental delays, low muscle tone (hypotonia), and liver dysfunction.
  • Progressive neurological deterioration or failure to meet developmental milestones in infancy or early childhood.
  • Identification through newborn screening (where available) showing abnormal very-long-chain fatty acid profiles.

How to prepare

  • Comprehensive diagnostic evaluation including blood tests for phytanic acid, genetic counseling, and metabolic panel.
  • Baseline assessments: detailed neurological exam, vision and hearing tests, and liver function tests.
  • Consultation with a metabolic dietitian to plan a strict phytanic acid-restricted diet.
  • Formation of a multidisciplinary care team (neurologist, ophthalmologist, audiologist, physiotherapist).
  • Education for parents/caregivers about the disease, dietary management, and long-term care requirements.

Risks & possible complications

  • Progressive and irreversible vision loss (retinitis pigmentosa) despite management.
  • Progressive sensorineural hearing loss leading to deafness.
  • Neurological complications including seizures, intellectual disability, and peripheral neuropathy.
  • Liver dysfunction and potential for cirrhosis over time.
  • Growth failure and nutritional deficiencies due to restrictive dietary management.
  • Bone abnormalities (osteoporosis) and skeletal issues.

Recovery & hospital stay

  • Management is lifelong, with no cure; 'recovery' refers to stabilization and supportive care.
  • Strict, lifelong adherence to a specialized diet low in phytanic acid (avoiding dairy, beef, lamb, and certain fish).
  • Regular follow-ups with the neurologist and multidisciplinary team for monitoring of vision, hearing, neurology, and nutrition.
  • Ongoing physical, occupational, and speech therapy to maximize motor function and communication skills.
  • Use of supportive devices like hearing aids, visual aids, and mobility assistance as needed.
  • Psychological and social support for the patient and family to cope with a chronic condition.
  • checked Typical hospital stay: 3-7 days (for initial diagnostic workup and care planning)
  • checked Expected recovery time: Lifelong management (no recovery period in the traditional sense)

Frequently Asked Questions

If you are considering infantile refsum disease in Turkey, these questions and answers can help you make a confident, informed decision.

Procedure cost in other countries

Here is an overview of how the estimated cost, hospital stay, and recovery time for infantile refsum disease compare across other countries where we have data.

Country Estimated cost range Typical stay Recovery time View details
India USD 551 – USD 2,202 3-7 days (for initial diagnostic workup and care planning) ~ Lifelong management (no recovery period in the traditional sense) Know More
Turkey USD 4,098 – USD 16,391 3-7 days (for initial diagnostic workup and care planning) ~ Lifelong management (no recovery period in the traditional sense) Know More

Top hospitals for Infantile Refsum Disease in Turkey

These partner hospitals in Turkey have dedicated neurology teams and experience managing patients undergoing infantile refsum disease.

  • Star
  • Star
  • Star
  • Star
  • Star
15+ Rating

VM Medical Park Pendik Hastanesi

  • IconInstabul, Turkey
  • Icon150 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
51+ Rating

Istinye Üniversitesi Hastanesi Liv

  • IconInstabul, Turkey
  • Icon140 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
12+ Rating

Liv Hospital Ankara

  • IconInstabul, Turkey
  • Icon140 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
4940+ Rating

Medical Park Bahçelievler

  • IconInstabul, Turkey
  • Icon104 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
169+ Rating

Medical Park Gaziosmanpaşa

  • IconInstabul, Turkey
  • Icon117 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
112+ Rating

Liv Hospital Bahçeşehir

  • IconInstabul, Turkey
  • Icon38 Doctors
  • Star
  • Star
  • Star
  • Star
  • Star
52+ Rating

Medical Park Trabzon

  • IconInstabul, Turkey
  • Icon51 Doctors
PATIENT REVIEW

Saanvi Malhotra is a 10-month-old girl,...

Saanvi Malhotra is a 10-month-old girl, the first child of young parents who immigrated from India. Her parents first noticed something was wrong when she was 4 months old; she wasn't reaching for toys, her eyes seemed to wander, and she was unusually floppy. By 8 months, she had lost the few motor skills she had gained. Her pediatrician referred her to a neurologist after noticing her poor growth and abnormal eye movements. The neurologist, suspecting a peroxisomal disorder, recommended genetic testing and specific biochemical tests for Infantile Refsum Disease (IRD). The diagnostic process was a long wait for blood and urine tests, followed by a confirmatory genetic panel. The experience was stressful, involving multiple clinic visits and blood draws that distressed Saanvi and her parents. The post-diagnosis outcome was a confirmed IRD diagnosis. There is no cure, but the treatment plan involved a strict diet very low in phytanic acid (found in dairy and certain meats), vitamin supplements, and physical therapy. The emotional journey was devastating. Her parents grappled with grief, guilt, and fear for their daughter's future. After the diagnosis, while heartbroken, they found a direction. They connected with a support group and focused on managing her diet and therapy, finding strength in advocacy and small improvements in her alertness.